16.73
4.04%
0.65
Dopo l'orario di chiusura:
17.09
0.36
+2.15%
Corbus Pharmaceuticals Holdings Inc Azioni (CRBP) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
74.96%
-0.177
|
-0.707 | -0.7634 | -0.7756 | -0.678 |
Operating Expenses
|
4.76%
9.6227
|
10.10 | 9.4879 | 8.189 | 17.30 |
Benefits Costs and Expenses |
8.10%
6.7218
|
7.3144 | 9.2899 | 8.0083 | 17.07 |
Costs And Expenses |
8.10%
6.7218
|
7.3144 | 9.2899 | 8.0083 | 17.07 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Depreciation and Amortization |
2.78%
0.1517
|
0.1476 | 0.1528 | 0.1583 | 0.1819 |
Operating Income/Loss |
4.76%
-9.6227
|
-10.10 | -9.4879 | -8.189 | -17.30 |
Net Interest Income/Expense |
74.96%
-0.177
|
-0.707 | -0.7634 | -0.7756 | -0.678 |
Nonoperating Income/Loss |
30.84%
2.724
|
2.082 | -0.5653 | 0.5949 | -0.4478 |
Income/Loss From Continuing Operations Before Tax |
14.00%
-6.8988
|
-8.0214 | -10.05 | -8.7838 | -17.74 |
Income/Loss From Continuing Operations After Tax |
14.00%
-6.8988
|
-8.0214 | -10.05 | -8.7838 | -17.74 |
Net Income/Loss
|
14.00%
-6.8988
|
-8.0214 | -10.05 | -8.7838 | -17.74 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
25,558%
8.3105
|
0.0324 | 4.4236 | 4.2777 | 4.1816 |
Diluted Average Shares |
25,558%
8.3105
|
0.0324 | 4.4236 | 4.2777 | 4.1816 |
Basic Earnings Per Share |
53.63%
-0.83
|
-1.79 | -2.27 | -2.05 | -4.24 |
Diluted Earnings Per Share |
53.63%
-0.83
|
-1.79 | -2.27 | 2.05 | -4.24 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):